At the Medica international trade fair for the medical sector in Düsseldorf, Verhaert proposed a new AI-based technology that directly measures blood pressure through photoplethysmographic (PPG) signals in fingers, wrists and upper arms. It can be used for long-term monitoring of hypertension patients without the need of a sphygmomanometer. This enables new applications such as personalized drug dosage and dosage adaptation based on exact situationally established blood pressure measurements.
The technology combines feature-based deep learning and featureless machine learning algorithms, which results in a mean of 7 mm Hg of absolute error on the diastole and systolic blood pressure. Many people could benefit from this technology, as the European Society of Cardiology states that, even in lower-risk cardiovascular disease populations, such as Belgium and Germany, many people risk dying of heart diseases within the next 10 years.

